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Abstract
Background: Membrane microdomains represent dynamic membrane nano-assemblies enriched in signaling
molecules suggesting their active involvement in not only physiological but also pathological molecular
processes. The hyperlipidemic stress is a major risk factor of atherosclerosis, but its exact mechanisms of
action at the membrane microdomains level remain elusive. The aim of the present study was to determine
whether membrane-cytoskeleton proteome in the pulmonary tissue could be modulated by the
hyperlipidemic stress, a major risk factor of atherosclerosis.
Results: High resolution mass spectrometry based proteomics analysis was performed for detergent resistant
membrane microdomains isolated from lung homogenates of control, ApoE deficient and statin treated ApoE
deficient mice. The findings of the study allowed the identification with high confidence of 1925 proteins,
291 of which were found significantly altered by the modified genetic background, by the statin treatment
or both conditions. Principal component analysis revealed a proximal partitioning of the biological replicates,
but also a distinct spatial scattering of the sample groups, highlighting different quantitative profiles. The
statistical significant over-representation of Regulation of actin cytoskeleton, Focal adhesion and Adherens junction Kyoto
Encyclopedia of Genes and Genomes signaling pathways was demonstrated through bioinformatics analysis. The three
inter-relation maps comprised 29 of regulated proteins, proving membrane-cytoskeleton coupling targeting and
alteration by hyperlipidemia and/or statin treatment.
Conclusions: The findings of the study allowed the identification with high confidence of the main proteins modulated
by the hyperlipidemic stress involved in the actin-dependent pathways. Our study provides the basis for
future work probing how the protein activities at the membrane-cytoskeleton interface are dependent
upon genetic induced hyperlipidemia.
Keywords: Detergent resistant membrane microdomains, Hyperlipidemia, Actin cytoskeleton, Proteomics,
Mass spectrometry
Background
Atherosclerosis is a multi-factorial chronic disease,
which constitutes one of the leading causes of death
mainly in developed countries. Although for a long time
this pathology was considered a slow and irreparable
process, recent development has provided important
evidence that it is a multi-zonal, dynamic and when early
treated reversible process [1]. Endothelial cells are
especially implicated in the development and progres-
sion (or regression) of the atherosclerotic lesions,
being the first cell monolayer insulted by plasma bio-
chemical changes, undergoing inflammatory activation
in response to atherogenic stimuli such as modified
lipoproteins that accumulate in the arterial wall
generating atherosclerotic plaques [2, 3].
The pulmonary endothelium can be viewed as a discrete
organ regulating important functions, such as exchange of
solutes, modulation of vascular tone, control of homeosta-
sis, fibrinolysis, coagulation, regulation of vasculogenesis
and angiogenesis, interaction with platelets and leukocytes
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[4]. Although atherosclerotic plaques do not usually
develop in pulmonary vasculature, it has been stated that
the pulmonary endothelium in particular serves as a
biological determinant that can be modulated for health
improvement using angiotensin converting enzyme inhibi-
tors and statins [5, 6]. Published data demonstrated that
atherosclerotic stress factors such as high-fat diet [7, 8],
hypertension [9], reactive oxygen intermediates [10],
excessive NO production [11], overproduction of pro-
inflammatory cytokines, chemokines [12, 13] and
deregulation of coagulation and fibrinolysis [14, 15],
can activate the pulmonary endothelium, leading to
distortion of multiple signaling pathways, with signifi-
cant impact on the stability of atherosclerotic plaques
located in the lesion-prone area of the vascular tree.
All these data are directly correlated with the well-
established clinical profile of patients with advanced
atherosclerosis showing recurrent pulmonary diseases
and insufficient oxygenation associated with general
fatigue and limited physical efforts.
Detergent resistant membrane (DRM) microdomains
are small (10–200 nm), heterogeneous and dynamic
cholesterol and sphingolipid enriched domains that
compartmentalize cellular processes, such as cholesterol
homeostasis, and endocytosis [16]. Smaller DRM micro-
domains can coalesce together to form larger platforms
through protein-protein and protein-lipid interactions
[17]. For a long time, DRM microdomains, owing their
name to the classical procedure of extraction in non-
ionic detergents and flotation in a sucrose gradient [18],
have been associated with cell signaling [19, 20]. Their
proteomic profile, enriched in signaling proteins such
as heterotrimeric G proteins, non-receptor tyrosine
kinases and protein phosphatases [21–23], suggested
the active involvement in the molecular mechanisms
that control both the physiologic and the pathologic
cellular processes.
Along with the cellular junctions and glycocalyx coat,
the endothelial cell cytoskeleton plays an important role
in maintaining cellular structural integrity and signal
transduction in response to mechanical forces [24–26].
Previous studies demonstrated that under turbulent
flow, endothelial dysfunction is favored through
cytoskeletal remodeling, promoting atherosclerotic
processes by endothelial architecture alteration [27]. It
is also well established that inflammation of the
vascular bed is associated with endothelial cytoskeletal
redistribution, which leads to an increase in inter-
cellular gap size and paracellular permeability [28].
Closely associated with signaling molecules, cyto-
skeletal and adhesion molecules are routinely found
in DRM preparation, such as actin, myosin, vinculin, cofi-
lin, cadherin, filamin, ezrin, etc. [22, 29, 30]. The presence
of cytoskeletal proteins in the DRM microdomains
proteome is an indication that these microdomains ac-
tively interact with the cytoskeleton, providing the needed
energy and the stability for the proper function of aggre-
gated membrane microdomain structures and signaling
pathways [31].
Statins are lipid-lowering drugs that were developed
and tested clinically on the basis of their properties
to suppress cholesterol biosynthesis. They work by
selectively and competitively inhibiting 3-hidroxy-3-
methyl-glutaryl-coenzyme A (HMG-CoA) reductase
and by promoting the up-regulation of low density
lipoproteins-cholesterol receptors on the plasma mem-
brane [32, 33]. Various measurements of haemostatic pa-
rameters provide further demonstration for the beneficial
effects of statins on endothelial cells, including promotion
of a pro-fibrinolytic state [34]. Also, fluvastatin has been
shown to inhibit matrix metalloproteinase-1 expression
and oxidative damage in vascular endothelial cells, thus
improving endothelial dysfunction associated with athero-
sclerosis [35, 36].
ApoE deficient mice develop spontaneous atherosclerotic
lesions, even on a low fat chow diet [37, 38]. This model
was generated from C57BL6 mice by knocking out the
ApoE gene leading to Apo E deficient animals that showed
impaired clearing of plasma lipoproteins and development
of atherosclerosis. In a short time, they exhibit extremely
high level of plasma cholesterol and triglycerides and more
advanced aortic lesions than the fatty streaks observed in
normal inbred strains [39].
In the present study we added a supplementary stress
factor, the high fat diet to accelerate the development of
atherosclerotic lesions in ApoE knockout (ApoE KO)
mouse experimental model [40, 41]. The effect of statin
therapy was monitored in a similar lot of animals. The de-
signed workflow took advantage of the well-established
methodology to isolate DRM microdomains from lung tis-
sue of ApoE deficient mice to investigate the molecular
mechanisms specifically modified in atherosclerosis.
The high performance liquid chromatography tandem
mass spectrometry approach and appropriate prote-
omic bioinformatics analysis were used. In the end,
the evaluation of DRM microdomains proteome with
or without statin treatment was performed with
regard to the representative protein classes of actin-
dependent signal transduction pathways, namely:
Regulation of Actin Cytoskeleton, Focal Adhesion and
Adherence Junctions. The proteomic study revealed a
panel of differentially expressed proteins that play
pivotal roles in the molecular mechanisms of
membrane-cytoskeleton interactions in atheroscler-
osis. The selective proteins regulation by the statin
treatment was evaluated. The results were also
supported by the immunological validation method
that was applied for some of these proteins.
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Methods
Reagents and consumables
All chemicals used in this study were of electrophor-
esis, liquid chromatography or mass spectrometry
grade, unless otherwise specified. Sodium fluvastatin
was purchased from Novartis (Basel, Switzerland);
MES [2-(N-Morpholino)ethanesulfonic acid], sodium
chloride, urea, sodium deoxycholate (DOC), trizma
hydrochloride, DL-dithiothreitol (DTT), iodoacetamide
(IAA), N-acetyl-L-cysteine (NAC), ammonium bicar-
bonate, bicinchonic acid, Bradford reagent and all
solvents were provided by Sigma-Aldrich (Missouri,
USA). Sequencing grade modified trypsin was offered
by Promega (Wisconsin, USA). Protease inhibitor
cocktail Complete tablets was purchased from Roche
(Indiana, USA). C18 solid phase extraction columns
were acquired from Waters (Massachusetts, USA).
Western blot detection was performed using Enhanced
chemiluminescence plus reagent (GE Healthcare, Little
Chalfont, UK). Mouse anti-human caveolin-1 monoclonal
antibody, lot: 64023, clone: C060, catalogue number:
610058, BD Transduction Laboratories (Kentucky, USA),
rabbit anti-mouse polymerase I and transcript release fac-
tor (PTRF) polyclonal antibody, lot: GR7161-2, catalogue
number: ab48824 and mouse anti-beta actin, catalogue
number ab6276, clone AC-15 antibody from Abcam
(Cambridge, UK). Monoclonal anti-vinculin FITC, clone
hVIN-1, catalogue number F7053 and IgG-HRP secondary
antibodies either anti-mouse or anti-rabbit IgG peroxidase
conjugate from Sigma-Aldrich (Missouri, USA) were used
for immunoblotting experiments.
Experimental animal models
Healthy 6 weeks male laboratory mice (Mus musculus)
were used in the current study. The lot comprised a
Black C57 control group (C, n = 3) fed with standard
diet, a group of hyperlipidemic ApoE KO mice with the
same genetic background as the control group (A, n = 3),
that received four weeks a high fat diet (1 % cholesterol
and 15 % butter) and a similar statin treated group of
ApoE KO mice (At, n = 3) that after the four weeks of
high fat diet and installation of atherosclerosis were trans-
ferred to standard diet together with oral gavages of
fluvastatin sodium (10 mg/kg body/day) for another two
weeks. The statin treatment was initiated together with
starting of the low fat diet similar with the clinical
practice, allowing only the genetic factor to act during
statin administration. Thus, after two weeks of statin
therapy the animals were compared with the four
weeks atherosclerosis animals (group A) to clearly
evidence the effect of imposed standard diet associ-
ated with low cholesterol medication.
The mice were kept in the animal husbandry facility
under 12 h light/dark cycles with free access to food and
water. All animal experiments were conducted in
accordance with “International Guiding Principles for
Biomedical Research Involving Animals” (Council for
the International Organizations of Medical Sciences,
December 2012) and Romanian Law no. 471/2002. The
protocol was approved by the Ethic Committee of ICBP
“N. Simionescu” (Permit Number: 373).
Detergent resistant membrane microdomains isolation
DRM microdomains fractions were prepared as previ-
ously described [18]. Briefly, 200 mg of lung tissue
fragments were solubilized on ice in 1.8 ml MES-
buffered saline (MBS), pH 6.5 (containing: 25 mM
MES, 0.15 M NaCl) and 1 % Triton X-100 with the
use of a rotor-stator mechanical homogenizer (5 min
at high speed). The resulting lysate was adjusted to
40 % sucrose with 2 ml of 80 % sucrose in MBS and
placed on the bottom of an ultracentrifuge tube. A
discontinuous sucrose gradient was formed by gently
overlaying 4 ml of 30 %, followed by another 4 ml of 5 %
sucrose in MBS. The sucrose gradient tubes were placed
in the SW-41 rotor and centrifuged at 200,000 × g, for
19 h at 4 °C, using the Optima LE-80 ultracentrifuge
(Beckman-Coulter, Fullerton, USA). Fractions (n = 12)
were harvested from top to bottom, for biochemical deter-
minations and afterwards experiments. Protein quantifica-
tion was performed using bicinchoninic acid while
cholesterol level determination was realized using the
CHOD-PAP method (cholesterol assay kit, DIALAB
GMBH, Neudorf, Austria). To validate the significant
enrichment of the samples with endothelial plasma mem-
brane the angiotensin I converting enzyme (ACE) activity
was evaluated using Hip-L-His-L-Leu substrate, as previ-
ously described [42]. For each individual replicate, the two
fractions (4 and 5) enriched in protein and choles-
terol, with high ACE activity, were combined and di-
luted 5 times in MBS before a 4 h ultracentrifugation
(200,000 × g at 4 °C). The resulting supernatant was
removed and the pellet of each biological replicate
was stored at −80 °C and analyzed separately for
proper statistical significance evaluation.
SDS-PAGE and immunoblotting assay
Equivalent amounts of protein from the collected fractions
were separated by 12.5 % sodium dodecyl sulfate/poly-
acrylamide gel electrophoresis. The separated proteins
were silver stained and the gel image acquisition was per-
formed using ArtixScan 1100 scanner (Microtek, Hsinchu,
Taiwan). The proteins from similar gels were transferred
to nitrocellulose membranes and analyzed by Western
Blot assay. The nonspecific binding was blocked with 5 %
bovine serum albumin (BSA) in Tris-buffered saline (TBS)
containing 0.05 % Tween 20, pH 7.6. The blots were than
exposed for 2 h to the primary anti-caveolin-1 (0.25 μg/ml
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working concentration), anti-PTRF (1 μg/ml final concen-
tration), or anti-beta actin (0.5 μg/ml working concentra-
tion) antibodies in TBS with 1 % BSA. Incubation for 1 h
with appropriate secondary IgG-HRP antibodies was per-
formed and the chemiluminiscence reaction was recorded.
In the case of the vinculin antigen detection, only the first
monoclonal antibody (conjugated with FITC) was used.
For this situation, the specific excitation/emission FITC
filters were used inside the Typhoon 9500 laser scanner
(GE Healthcare, Uppsala, Sweden).
Preparation of DRMs for mass spectrometric analysis
Sample solubilization was conducted in a highly de-
naturant buffer containing 8 M urea (as main chao-
tropic agent), 1 % sodium deoxycholate (DOC) and
0.1 % Tris–HCl (pH 8.8). The solubilization was con-
ducted through powerful vortexing for 30 min on ice,
followed by occasional shakeup for another 3 h on
ice. The protein quantification was performed using
the Bradford reagent and a bovine serum albumin 5
point standard curve (0.1-1 μg/μl). The sample was
cleaned-up for lipids and salts by precipitation with
methanol/chloroform/water (4:2:4) combination. The
cysteine residues were reduced in freshly prepared
denaturant buffer, pH 8.8, (containing 8 M urea, 0.1 M
Tris–HCl, 0.1 mM EDTA and 20 mM DTT) for 60 min.
Alkylation of the reduced proteins was conducted using
80 mM IAA in 0.1 M Tris–HCl and 0.1 mM EDTA buffer,
for 90 min followed by quenching with 80 mM NAC in
0.1 M Tris–HCl and 0.1 mM EDTA buffer, for 30 min. All
these steps were performed in the dark, under continuous
stirring at room temperature. Before the digestion process,
the sample buffer was diluted up to 1 M urea using
50 mM ammonium bicarbonate (pH 8.8) and DOC was
added up to 1 % final concentration.
Proteolysis was performed overnight, at 37 °C, with
stirring, using a 1:20 enzyme to substrate quantity ratio,
using sequencing grade modified trypsin. After 14 h, the
resulted peptide mixtures were acidified to pH 2–3 with
formic acid for trypsin activity inhibition and DOC
precipitation. DOC was discarded following a 20 min,
20,000 × g, at room temperature centrifugation. The
desalting step was conducted using Sep Pek C18 columns.
The purified peptides were eluted using 0.1 % formic acid
in 80 % acetonitrile. The peptides were dried using
the Concentrator plus system (Eppendorf, Hamburg,
Germany) and stored at −80 °C until LC-MS analysis. Prior
to the LC separation, the peptides were resuspended in
0.1 % formic acid, 5 % acetonitrile solution to final concen-
tration of 0.5 μg/μl, using an ultrasonication bath (15 min).
Tandem LC-MS analysis
LC-MS/MS experiments were performed using the
Ultimate 3000 RSLC nano system (Dionex, California,
USA) coupled to the LTQ Orbitrap Velos hybrid mass
spectrometer (Thermo Scientific, California, USA). For
each analysis, the sample (1 μl) was loaded in triplicate,
into an Acclaim PepMap 2 cm× 75 μm i.d., C18, 3 μm,
100 A trap column (Dionex). The trap column was con-
nected to the Acclaim PepMap RSLC 15 cm× 75 μm i.d.,
C18, 2 μm, 100 A analytical column (Dionex, California,
USA). Solvent A was LC-MS grade water with 0.1 % (v/v)
formic acid, and solvent B was represented by LC-MS
grade acetonitrile with 0.1 % (v/v) formic acid. After wash-
ing the trap column for 3 min, peptides were eluted with a
gradient of 2–35 % solvent B over 48 min (70 min total
chromatographic method and MS acquisition) at 300 nl/
min flow rate. Dynamic nano-electrospray source housing
was utilized with uncoated SilicaTips, 12 cm length,
360 μm outer diameter, 20 μm inner diameter and 10 μm
tip inner diameter. For ionization, 1500 V of liquid junc-
tion voltage and 250 °C capillary temperature were used.
The mass spectrometer was operated in a top 6 data-
dependent configuration at 60 k resolving power for
full scan, with monoisotopic precursor selection en-
abled and mass correction by using lock mass, across
the 300–2000 m/z domain. The analyses were carried
out with collision induced dissociation (CID) fragmenta-
tion mode (with the m/z width of precursor window set to
2 and normalised collision energy of 35). The instrument
operating software was Xcalibur 2.1.0 QF03489 build 1140
and LTQ Orbitrap Velos MS 2.6.0 build 1050. All liquid
chromatography and mass spectrometry experiments pa-
rameters are provided as Additional file 1.
Database protein identification
Protein identification was performed using Proteome
Discoverer 1.4 (Thermo Scientific, California, USA).
The search engine was Mascot 2.4.1 (Matrix Science,
London, UK) and the taxonomy was set on Mus musculus
organism in UniProtKB/SwissProt fasta database, build
04.2013. A maximum of 2 missed cleavage sites were
allowed. A mass tolerance for the precursor was set on
10 ppm and for the fragment on 0.8 Da. Oxidation of me-
thionine and deamidation of asparagine and glutamine
were enabled as dynamic modifications while carbamido-
methylation of cysteine was set as fixed modification. The
search workflow contained also a Percolator validation
node [43] using a decoy database search with a FDR target
lower than 0.05. The validation was based on the q-value.
Proteins identified with only one peptide were verified
manually. Proteome Discoverer Deamon 1.4 was utilized
for performing raw file combination of replicate samples
as well as batch searches for each biological condition.
Label-free quantification
The label free relative quantification on the precursor
level was performed with SIEVE 2.1 software (Thermo
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Scientific) that aligns MS spectra over retention time for
different experimental conditions and detects frames that
change along the different biological and technical repli-
cates [44]. The parameters selected for alignment and
frame detection needed for abundance calculation were as
follows: MZ start: 300; MZ stop: 2000; PCA Process: force
calculation; RT start: 0.01; RT stop: 69.99; alignment
bypass: false; alignment min intensity: 1000; correlation
bin width: 1; max RT shift: 0.2; tile size: 300; frames from
MS2 scan: true; MZ width ppm: 10; RT width: 1.
The chromatographic alignment was founded on a
scalable adaptive tiled algorithm, in which pairs of full
scan spectra were compared and the spectra were then
separated into bins of equal size. Then, a correlation
between the two spectra (from each raw file) was calcu-
lated and the spectrum to spectrum correlations were
used to construct a matrix. An optimal path through the
matrix was determined, overlapping tiles were con-
structed continuing the path and when the full plane
was tiled, a final alignment score was calculated, where a
value of 1 represents a perfect alignment, which is only
possible for the reference file chosen for the alignment.
The ion score for peptide rescoring criteria was set at
minimum 2. For minimization of technical errors, we
performed normalization on the frame level, using the
total ion chromatogram (TIC) normalization method,
where the ion current was tallied between RT start (0.01)
and RT stop (69.99). The calculation process derived
from variance weighting, in which ratios were combined
using 1/variance as weighting factor, where variance is
the square of the standard deviation of the ratio. The fil-
tering formula for detecting relevant differences among
the distinct biological groups included the following
parameters: a coefficient of variation below 30 % for all
replicates, the fragmentation set to be performed only on
the C12 monoisotopic peak (PRELEMENT= 0) and the
detected frames to be associated with an identified peptide
(GOOD ID= 1). The frames were manually checked for
proper peak shape and overlapping of extracted ion chro-
matograms. After SIEVE filtering process, a cut-off of sig-
nificance (P < 0.05) and ratio threshold (1.5 fold up- or
down-regulation) was set at the protein level.
Data mining, protein annotation and pathway analysis
General and detailed description of the various properties
of proteins from our data and annotation based on gene
ontology comparison (cellular component, molecular
function and biological process) were obtained using a
trial version of Protein Center software (Thermo Scien-
tific). Protein Center databases were checked for protein
quantity alterations and to match qualitative evaluation,
integrate and project quantitative data onto over-
represented Kyoto Encyclopedia of Genes and Genomes
(KEGG) signaling pathways, publically available, online
pathway database of molecular interactions from within
specific organisms, pioneered by Kanehisa and his cola-
borators [45]. To estimate if a certain category of feature
was disproportionately represented in a data set, statistical
tests were carried out for a subset of interesting proteins
(differentially expressed proteins from the A and At
category vs. the C group). A statistical correction was used
in Protein Center analysis which was based on the method
suggested earlier [46]. This method corrects P-values
based on the False Discovery Rate (FDR). Thus, a signifi-
cance FDR level of 5 was chosen for the comparison of
our differentially expressed proteins with the Mus muscu-
lus proteome reference set and an over-represented KEGG




For the acceleration of the onset and development of
atherosclerotic plaques, the ApoE KO mice (A group)
received a hyperlipidemic diet. Indeed as previously
published, introducing the high fat diet results in
development of the atherosclerotic lesion about seven
weeks sooner when compared to the standard fed
ApoE KO mice [39, 40]. In the present study, the
body weights of the hyperlipidemic (A) (20.8 ± 0.24 g)
as well as the statin treated hyperlipidemic group
(At), (20.2 ± 0.22 g) remained almost constant, with-
out any statistical significant changes, when compared
to control (C) group (20.1 ± 0.38 g). However, the
serum cholesterol (461.57 ± 49.39 mg/dl) and trigly-
ceride (125.67 ± 10.19 mg/dl) levels were statistically
increased (P < 0.001) in the A group when compared
to those of the control, in which the serum choles-
terol and triglyceride levels were 65.85 ± 1.56 mg/dl
and 46.42 ± 1.85 mg/dl respectively. As expected, the
statin treatment significantly reduced both the choles-
terol (109.11 ± 14.65 mg/dl) and triglyceride levels
(54.02 ± 0.91 mg/dl) of the At group to levels compar-
able to those in the control C. Since it is impossible
to compare the statin effect in the same animals, we
did evaluate the two weeks statin administration out-
come with the atherosclerotic status reached by the
animals with genetic and high fat diet induced hyper-
lipidemia (A group), just before the statin therapy.
The described assessment closely matches the human
patient situation receiving the statin administration
together with low fat diet recommendation and may
reveal clear evidence of the cholesterol lowering drug
effect in the atherosclerotic committed animals (ApoE
deficient mice), irrespective of the received diet.
Previously, our published data showed that experi-
mental A group developed substantial atherosclerotic
lesions in the proximal aorta and valves [7]. The mild
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fatty streaks developed by animals in the At group
(statin treated) were found in good correlation with
the serum lipid levels, similar to those in our current
At experimental group, documenting that the statin
therapy, as expected, will most likely delayed the de-
velopment of the atherosclerotic plaques [7].
Characterization of isolated DRM microdomains
DRM microdomains were isolated from lung tissue,
which has the highest surface of endothelial cells in a
body. The biochemical determinations performed on the
sucrose gradient fractionated Triton X-100 extract
revealed the 4th and the 5th fractions as the right candi-
dates for further proteomic analysis. Namely, both
cholesterol and protein levels were increased in these
fractions (Fig. 1a, c). In addition, the concentration of
cholesterol was higher both in the A and At groups as
opposed to the control C (Fig. 1a). The small difference
observed between the cholesterol level in the 4th and 5th
fractions of DRM isolated from A and At groups proved
to be non-statistically significant. To assess that DRM
microdomains were mostly of endothelial origin we posi-
tively identified ACE protein (P09470 Uniprot access
code for angiotensin I converting enzyme), a marker of
endothelial cell plasma membrane, through LC-MS/MS
experiments (with a Mascot score of 125.91) and mea-
sured its activity. Indeed, the fractions enriched in DRM
microdomains presented a higher level of ACE activity.
Moreover, the ACE activity of the atherosclerotic animal
group A was found to be higher than in the control
group C suggesting an activation of the endothelial cells
under hyperlipidemia stress (Fig. 1b).
In the present study, caveolin-1, polymerase I and
transcript release factor (PTRF) together with flotilin 1
[7, 31], glycosylphosphatidylinositol (GPI)-anchored
proteins, namely Thy-1 membrane glycoprotein and
carboxypeptidase M, accepted as DRM resident proteins
[31, 47, 48], were also identified (with Mascot scores >
200) by mass spectrometry. In the present data mining
extension of the same experimental model, the caveolin-1
and PTRF were also confirmed by immunological de-
tection (Fig. 1d) to be enriched in fractions 4 and 5,
thus validating the DRM isolation. Additionally, mass
spectrometry experiments evidenced high identifica-
tion Mascot scores for caveolin-1 and PTRF (335.21
and 828.94 respectively).
Shotgun proteomic qualitative and label-free quantitative
analysis
The DRM microdomains comparative shotgun prote-
omic LC-MS experiments revealed a high plethora of
resident and membrane-associated proteins involved
in molecular interactions and enzymatic functions.
High performance nano-liquid chromatography mass
spectrometry experiments were conducted for proteome
characterization of isolated DRM microdomains. Thus,
1279 proteins were identified in the control (C), 1233 pro-
teins in the atherosclerotic samples (A) and 1239 proteins
came from the treated animals (At), using raw file com-
bination for replicate samples (Fig. 2a).
Label free relative quantification procedure revealed a
total of 291 differentially expressed proteins located in
DRM microdomains of the A and/or At groups, relative
to the control group (Additional file 2: Table S1). The
chromatographic alignment of the biological groups re-
vealed a nearly perfect overlapping of the base peak
chromatograms (shown in Additional file 3: Figure S1),
with the lowest calculated alignment score of 0.882, indi-
cative of the fact that the framing process gave rise to
high confidence in detecting low variation m/z and re-
tention time values between biological groups.
For the entire experiment we considered only the
peptides with unique protein assignments resulting in a
total of 1925 proteins (10180 uniquely assigned peptides)
passing the selection criteria (see the Methods section).
The retained 291 proteins passing the variance and
significance relevance criteria were selected from a total
of 29993 detected frames and 1925 imported proteins
(Fig. 2b). We also chose to select certain proteins for
discussion which were in close proximity of the variance
and significance thresholds. For quality assessment of
experiment input Principal Component Analysis (PCA)
was performed within SIEVE 1.4. PCA represents an un-
supervised clustering algorithm used to discover and to
reduce the dimensionality of a data set, simultaneously
retaining the information present in the data [49, 50].
Three variables, the so-called principal components,
were generated using the Sieve PCA algorithm (Fig. 2c).
The updated, post-filtering 3D representation of the
principal component analysis revealed the excellent
differentiation of the atherosclerosis (A) and statin
treated atherosclerosis (At) vs. control (C) group. The
distinct spatial scattering of the two biological conditions
against the control shows different quantification
profiles of the features detected in the precursor
chromatograms and thus a validation of the proteomic
alteration affecting DRM microdomains proteins of the
genetic induced hyperlipidemic mice (A group). The
statin treatment (At group) induced a shift in the quanti-
fication pattern as opposed to the wild type (C group),
as well.
Gene ontology (slim version) data from Protein Center
of the biological replicates revealed that the majority of
the identified proteins are in fact of membrane origin
(shown in Additional file 4: Figure S2). We have to stress
out though that the classification by the different
categories is not absolute and may in fact cause often
data overlapping of protein function or localization.
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There are few studies in the literature that describe
DRM proteome using the Gene Ontology database
[51–53], in particular for the lung isolated DRMs, so
insight into the localization, molecular function and
biological process of the DRMs’ proteins will be valuable
for future studies. Different classes were particularly well
represented in the pool of proteins identified against the
pre-existent Gene Ontology Slim data protein classifica-
tion. For example: the cytoplasm and membrane origin
proteins in the Cellular Components, cell communication,
cell organization and biogenesis, metabolic process and
regulation of biological process proteins in the Biological
Processes and protein binding, catalytic activity, metal ion
binding, nucleotide binding and transporter activity
proteins in the Molecular Function appeared to be prefer-
entially modified in hyperlipidemia.
Analysis of DRMs’ protein expression in actin-dependent
signaling pathways
Hyperlipidemia and statin treatment demonstrated
alteration of the DRMs’ protein expression in selective
signaling pathways. The LC-MS/MS comparative
analysis examined in Protein Center evidenced 13 over-
represented statistically significant signaling pathways
Fig. 1 Biochemical parameters and validation of detergent resistant membrane microdomains. Isolated DRM microdomains showing that the 4th
and 5th fractions were enriched in cholesterol (a), protein (c) and presenting high ACE activity (b). Representative silver stained 1D SDS-PAGE and
Western Blot images of fractions 4 through 6 (d). Immunoblot experiments were performed for caveolin-1 and polymerase I and transcript release
factor (PTRF) as DRM microdomain protein markers. Fractions 4 and 5 were chosen for further proteomic experiments as DRM microdomains
enriched fractions. Molecular weight protein standards (M) are also shown
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Fig. 2 (See legend on next page.)
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(Additional file 5: Table S2), (FDR P-value < 0.05) and
relevant for the cellular processes that revealed various
numbers of up- or down-regulated proteins. Among them,
proteins from three signaling pathways, namely: Regula-
tion of actin cytoskeleton (FDR P-value = 8.56E-4), Focal
adhesion (FDR P-value = 9.36E-3) and Adherens junction
(FDR P-value = 2.62E-4) proved to be particularly modi-
fied under the hyperlipidemic stress. The extreme inter-
dependency of the three chosen KEGG signaling pathways
at the cytoskeleton-membrane-exoplasmatic leaflet of the
endothelial cell interface was the main reason for their se-
lection, as it is well evidenced in the very complex Fig. 3.
Fluvastatin therapy showed selective outcome on different
proteins in these pathways. The 29 proteins found to be
involved in the mentioned inter-related membrane cyto-
skeleton pathways were listed with the annotation param-
eters in Table 1 and represented in Fig. 4. In the first
stage, the present paper will be focused on these three
over-represented signaling pathways analysis; the others
will follow shortly.
Regulation of actin cytoskeleton pathway
The Gene Ontology analysis of the 291 differentially
expressed proteins of the isolated DRM microdomains
demonstrated notable enrichment in membrane and cyto-
skeleton proteins. The regulation of actin cytoskeleton was
found as an over-represented KEGG pathway map (Fig. 3),
with 21 proteins (including protein species) out of a total
of 159, which were identified and differentially expressed
in the label free quantification process. While the expres-
sion of some proteins was drastically up-regulated by
hyperlipidemic stress, others were down-regulated or
seemed to be unaffected significantly (Table 1). For
example, actin cytoplasmatic 1 and 2 were found over-
expressed both in the hyperlipidemic model (with ratios
over the control of 1.48 ± 0.16 and 1.42 ± 0.26 respect-
ively) as well as in the treated hyperlipidemic group (with
ratios over the control of 1.78 ± 0.18 and 2.38 ± 0.30
respectively). A similar trend was found for alpha actinin
2 and ARF GTP-ase-activating protein GIT1. The
alpha-3 and alpha-8 integrins were found significantly
under-expressed in the treated hyperlipidemic group,
with the hyperlipidemic condition having almost no
effect over their expression. Similarly, integrin alpha-1
was found significantly under-expressed in the statin
treatment group, but the hyperlipidemic condition
up-regulated its expression.
In both A/C and At/C cases, a lower protein expression
was revealed also for guanine nucleotide-binding pro-
tein subunit alpha-13, integrin beta-1, moesin, radixin,
Ras-related C3 botulinum toxin substrate-1, serine/
threonine-protein phosphatase PP1 beta catalytic subunit
and vinculin, presenting a more pronounced character in
the statin treatment group. Ezrin, myosin-10, myosin-9
and transforming protein RhoA were found as well under-
expressed (affected especially by the statin treatment).
Alpha actinin was also identified in this signaling pathway,
although its expression was not significantly altered in
either two conditions when compared to control group.
Regarding the changes induced by fluvastatin treatment,
different results could be distinguished. Comparing
the A/C with At/C rations revealed either up- or
down-regulation tendency for the majority of the identi-
fied proteins. However, the effect is reversed for a few
proteins: alpha-actinin-1, transforming protein RhoA and
integrin alpha-1 as shown in Fig. 4.
Immunological validation of actin, cytoplasmatic 1
(P60710, also known as beta-actin) and vinculin (Q64727)
abundance alteration detected by mass spectrometric
analysis was performed using the Western Blotting
methodology (Fig. 5). The experiments confirmed with
high significance that indeed the hyperlipidemic condition
and statin treatment lead to a higher protein expression in
the case of beta-actin when compared to the control
samples (A/C: 2.683 ± 0.354; At/C: 3.633 ± 0.251) and a
lower expression of vinculin (A/C: 0.747 ± 0.05; At/C:
0.649 ± 0.01).
Focal adhesion proteins
Another KEGG signaling pathway that was found over-
represented by the proteins that were differentially
expressed in A and At animals was the one that involves
focal adhesion proteins (Fig. 3). Besides the inherently
common proteins involved in the process of regulation of
actin cytoskeleton, some other proteins demonstrated
altered expression: integrin-linked protein kinase pre-
sented a statistically significant lower expression in the
hyperlipidemic animal group. A more pronounced under-
(See figure on previous page.)
Fig. 2 Liquid chromatography – tandem mass spectrometry data. a Numerical distribution diagram showing the identified proteins in detergent
resistant membrane microdomains in: control group (C: 1279 proteins), ApoE KO mice that received hyperlipidemic diet (A: 1233 proteins) and
ApoE KO mice fed hyperlipidemic diet followed by statin treatment (At: 1239 proteins). Commonly identified (932 proteins) as well as uniquely
attributed proteins (C: 191 proteins; A: 134 proteins and At: 160 proteins) are depicted. b The normalized ratio was plotted against the significance
level for the proteins which were altered either in the hyperlipidemic condition (A/C: red circles) or the statin treatment in genetic hyperlipidemic
stress (At/C: blue circles) or both of them. The horizontal line represents the minimum significance value threshold (P < 0.05), while the vertical lines
denote the 1.5 fold alteration cut-off. The purple color signifies the superposition of red and blue circles. c Spatial quantitative scattering profile for the
biological replicates of each group was performed for the control group (blue dots), ApoE KO mice fed hyperlipidemic diet (green dots) and ApoE KO
mice that received hyperlipidemic diet followed by statin treatment (red dots)
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expression caused by the statin treatment was observed for
Ras-related protein Rap-1A and talin-1. Catenin beta-1 was
also down-regulated in the At group, although not statisti-
cally significant. The hyperlipidemia compensatory effect of
statin therapy could be observed for few proteins, three of
them being involved in both actin cytoskeleton and focal
adhesion regulation pathways: alpha-actinin-1, transform-
ing protein RhoA and integrin alpha-1 besides the ras-
related protein Rap-1A (Fig. 4). In total, 17 out of the 145
proteins that map the KEGG pathway were found to be
differentially expressed supporting the altered organization
of intercellular focal adhesion in hyperlipidemia.
Fig. 3 Actin dependent signal transduction pathways of identified and quantified detergent resistant membrane microdomains proteins. The
interaction map comprises the currently discussed mass spectrometric identified proteins (red bordered boxes) and differentially expressed proteins
(green filled red bordered boxes) and were integrated in the over-represented Regulation of actin cytoskeleton, Focal adhesion and Adherens junction
signaling pathways. The complex signaling network represents the combination of map04810, map 04510 and map 04520 KEGG signaling pathways.
Abbreviations for the discussed proteins: Ras: Ras-related protein R-Ras; MEK: mitogen-activated protein kinase kinase 1; F2RCD14: coagulation factor II,
CD14 antigen; DOCK180: dedicator of cytokinesis protein; VWF: von Willebrand factor; Cav: caveolin; Gβγ: Guanine nucleotide-binding protein G(I)/G(S)/
G(O) subunit gamma-12; Arp2/3: Actin-related protein 2/3 complex subunit 1B and 3; PIR121: Cytoplasmic FMR1-interacting protein 1; PFN: profilin;
CFN: Cofilin-1; ZYX: Zyxin; MLC: Myosin regulatory light polypeptide 9; MLCK: Myosin light chain kinase 2; mDia: Protein diaphanous homolog 1; ACTN:
actinin: VCL: vinculin; TLN: talin; ITG: integrin; Rap-1: Ras-related protein Rap-1A; Rac: Ras-related C3 botulinum toxin substrate 1; ILK: Integrin-linked
protein kinase; MLCP: Serine/threonine-protein phosphatase PP1-beta catalytic subunit; RhoA: Transforming protein RhoA; ERM: ezrin/radixin/moesin;
GIT1: ARF GTPase-activating protein GIT1; Yes: Tyrosine-protein kinase Yes; IQGAP1: RasGTPase-activating-like protein IQGAP1; CKII: Casein kinase II
subunit alpha; Gα12,13: Guanine nucleotide-binding protein subunit alpha-13
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Adherens junction proteins
The adherent junction KEGG signaling pathway was
also over-represented by the statistical Protein Center
analysis, with 12 differentially expressed proteins out
of 55 possible candidates (Fig. 3); amongst them,
tyrosine-protein kinase Yes was unaffected by the
hyperlipidemic condition (A), whereas the statin treat-
ment (At) significantly lowered its expression. Catenin
alpha-1 was significantly up-regulated both by the
hyperlipidemic condition (A) as well as by statin
treatment (At). Casein kinase II subunit alpha pre-
sented a higher expression in the atherosclerotic
animals, while the statin treatment altered its expres-
sion, with an A/C ratio reaching almost the control
level (Table 1).
Other proteins that are integrated into these three
above mentioned signaling pathways that were identified
by the present LC/MS-MS experiments, but were not
found to be differentially expressed were included as
Additional file 6: Supplementary information.
Table 1 Catalogue of differentially expressed proteins of DRM microdomains isolated from ApoE KO mice fed hyperlipidemic diet
(A) and ApoE KO mice that received hyperlipidemic diet and statin treatment (At) against the control group (C). Table reports the
SwissProt/UniProt Accession Number, protein description, molecular weight (MW), Mascot identification score, SIEVE normalized
ratios of A over C and of At over C, their respective standard deviations and p-values
















Q9JI91 Alpha-actinin-2 103.8 353.78 2.875 0.825 1.84E-03 3.030 0.865 1.72E-03
P26231 Catenin alpha-1 100.1 100 2.212 0.193 5.04E-04 2.230 0.226 5.03E-04
P63260 Actin, cytoplasmic 2 41.8 5740.2 1.422 0.265 1.49E-02 2.386 0.305 1.10E-04
P60710 Actin, cytoplasmic 1 41.7 5483.9 1.483 0.163 4.84E-05 1.785 0.184 1.80E-06
Q68FF6 ARF GTPase-activating protein GIT1 85.2 62.49 1.590 0.610 6.57E-02 1.308 0.369 8.19E-02
Q60737 Casein kinase II subunit alpha 36.5 45.1 1.532 0.485 8.67E-02 1.267 0.274 5.76E-02
Q61739 Integrin alpha-6 97.3 122.1 1.499 0.175 1.12E-03 1.022 0.066 2.41E-01
Q3V3R4 Integrin alpha-1 130.7 236.53 1.325 0.065 3.38E-09 0.598 0.0308 3.26E-08
P62835 Ras-related protein Rap-1A 21.0 444.1 1.063 0.235 4.03E-01 0.747 0.156 8.04E-02
Q04736 Tyrosine-protein kinase Yes 92.38 60.6 1.008 0.090 5.49E-01 0.706 0.066 8.97E-05
Q9QUI0 Transforming protein RhoA 21.8 242.8 1.018 0.114 7.23E-01 0.741 0.083 1.42E-02
Q9QZQ1 Afadin 202.0 206.4 0.996 0.129 1.84E-03 0.559 0.051 2.40E-06
P09055 Integrin beta-1 88.2 333.2 0.989 0.048 5.76E-01 0.575 0.021 5.21E-11
Q02248 Catenin beta-1 85.4 2060.4 0.973 0.514 9.08E-01 0.740 0.255 1.97E-01
P27601 Guanine nucleotide-binding
protein subunit alpha-13
44.0 108.65 0.938 0.252 6.44E-01 0.550 0.230 3.39E-02
Q7TPR4 Alpha-actinin-1 103.0 1300.8 0.940 0.229 3.63E-02 1.029 0.190 3.50E-02
P63001 Ras-related C3 botulinum toxin substrate 1 21.4 111.49 0.932 0.057 2.94E-01 0.611 0.052 2.37E-06
P26041 Moesin 67.7 1657.9 0.913 0.024 2.01E-02 0.605 0.017 9.9E-20
P26040 Ezrin 69.4 594.85 0.904 0.068 3.22E-03 0.732 0.062 4.39E-04
P26043 Radixin 68.5 691.5 0.871 0.106 3.00E-01 0.694 0.053 3.37E-05
Q62470 Integrin alpha-3 116.7 178.09 0.846 0.049 2.24E-02 0.543 0.0373 5.97E-09
Q61879 Myosin-10 228.9 3486.6 0.843 0.028 2.04E-08 0.778 0.019 9.9E-20
A2ARA8 Integrin alpha-8 117.5 69.83 0.803 0.232 2.51E-01 0.537 0.108 1.11E-02
P62141 Serine/threonine-protein phosphatase
PP1-beta catalytic subunit
37.2 61.83 0.779 0.124 5.84E-02 0.598 0.103 1.50E-02
Q8VDD5 Myosin-9 226.2 7387 0.741 0.089 4.55E-03 0.742 0.056 2.71E-03
Q64727 Vinculin 16.6 2596.1 0.755 0.315 2.53E-01 0.685 0.301 1.69E-01
P26039 Talin-1 269.7 3143 0.728 0.022 5.00E-10 0.684 0.020 2.19E-12
Q9JKF1 RasGTPase-activating-like
protein IQGAP1
188.7 188.6 0.696 0.186 6.47E-02 0.699 0.193 6.48E-02
O55222 Integrin-linked protein kinase 51.3 330.25 0.668 0.060 9.41E-05 0.704 0.045 1.05E-03
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Discussion
High performance LC-MS proteomic analysis evidently
demonstrated that the replicates of the same biological
condition discussed in this work, by Principal compo-
nent analysis (PCA), clustered together on the same
surfaces of the PCA 3D graphical representation (Fig. 2c).
At the same time, the three experimental conditions
(C, A, and At) revealed a distant partitioning from
one another, corroborated with the different prote-
omic composition of the three experimental groups.
Thus, the PCA applied test showed that the differ-
ences found between the three sample groups were
consistent, underlying a biological significance.
Since hyperlipidemia is the main risk factor in the
development of atherosclerosis and our previous data [7]
demonstrated the specific induced changes in the prote-
omic composition of membrane microdomains, we
extended the proteomic analysis. LC-MS/MS technology
allowed the identification with high confidence (high ion
scores, large protein identification coverage) of 29
proteins associated with DRM microdomains isolated
from control (C), atherosclerotic ApoE deficient (A) and
statin treated ApoE deficient mice (At). These proteins re-
sulted to be associated with three key signaling pathways
that proved to be targeted by the hyperlipidemic stress. In
the present study, we focused on the interaction of DRM
proteins with the cytoskeleton elements resulting in regu-
lating membrane microdomains-associated signaling
events since the actin-dependent signal transduction
pathways (Actin cytoskeleton, Focal adhesion proteins and
Adherens junction proteins) are over represented in our
experimental condition. It is evident that hyperlipidemia
induced profound changes in the expression (up- or
down-regulated) of 291 proteins with different cellular
location and function and 29 of them are closely related
to the DRM-cytoskeleton events. The results are not
surprising since the repetitive events of polymerization/
depolymerization of the monomer units of actin is the
main source of energy and movement for multiple
biological functions that take place in the cells and at the
plasma-membrane level [54]. Endothelial-derived foam
cells showed a modified pattern of actin and vinculin
localization [55]. From the current mass spectrometric
study, we can also evidence a cytoskeleton alteration. We
observed that the statin treatment doesn’t diminish the
hyerlipidemic stress up to the basal level, but determines
an even more pronounced effect on the actin and vinculin
mass spectrometric abundance levels (Fig. 5), (a higher
normalised ratio of At/C than A/C in the case of actin
and a smaller normalised ratio of At/C than A/C in the
case of vinculin). The exposure of endothelial cells in
culture to oxLDL (as atherogenic risk factor) also induced
low plasma membrane expression of the lipid raft marker
GM1 [56] and internalization of endothelial caveolin 1
[57]. Previous studies demonstrated that inhibition of
actin filament polymerization interferes with vasodilatory
Fig. 4 Graphical overview of differentially expressed proteins identified in actin dependent signal transduction pathways. The proteins listed in
Table 1 were found to be part of Regulation of actin cytoskeleton, Focal adhesion and Adherence junction over-represented signaling pathways
targeted by hyperlipidemia and statin therapy
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signaling in human coronary arterioles and the pulmonary
circulation, which may suggest a crucial role for endothelial
cytoskeleton integrity in modulating endothelial-dependent
vasodilator signal transduction [58–60]. Although statins
are known to reduce lung inflammation through tetraspa-
nins modulation [61], there is plenty of published evidence
that statin treatment may have side effects by inducing
mild to severe myopathy, increased risk of diabetes
and abnormalities in liver enzyme tests in patients
receiving this drug [62]. In this context, our results
regarding the significant modulation in the expression
of actin cytoskeleton proteins are highly informative
for pinpointing several altered protein molecules that
could provide the basis for future functional studies.
Fig. 5 Immunological validation of mass spectrometry data for beta-actin and vinculin. Protein expression of beta-actin (actin cytoplasmatic 1)
and vinculin was detected in membrane microdomains enriched fractions by Western Blotting (a and c respectively), confirming the alteration
caused by the hyperlipidemic condition (A) and statin treatment (At) when compared to the control samples (C), detected by LC-MS/MS analysis
(b and d respectively). The Western Blotting experiments were repeated three times. Data are expressed as means ± SD. **p < 0.01, ***p < 0.001
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Previously published immunohistochemistry data support
our results that alteration in the expression and distribu-
tion of the cytoskeleton proteins, for example actin, ezrin
and cytokeratin-7, is present when normal and patho-
logical membrane microdomains were analyzed. Thus,
DRMs from intrauterine growth restriction (IUGR) and
preeclampsia (PE) pathologies showed clear different
features when compared to rafts from normal placenta,
underlining the consistency of the mass spectrometry
methodology used to reveal the stress induced proteomic
and signal transduction changes [63].
Some studies [64, 65] suggest a role of DRM microdo-
mains in regulating cytoskeleton-dependent processes,
including proliferation, trafficking, signaling, migration
and polarization. A malfunction or deregulation of DRMs
can interfere with the cytoskeleton interaction, blocking
essential cellular functions. In the very well established
model of immunological synapse, bidirectional interaction
takes place between membrane microdomains and the
actin cytoskeleton, in which signaling molecules localized
in DRM microdomains are partially responsible for the
reorganization of the actin cytoskeleton, while in turn this
is required for coalescing of the resident DRM (lipid rafts)
proteins necessary for the immunological synapse.
Additionally, raft-cytoskeleton interaction has been
demonstrated to take place in other cell types, as it is the
case for migration of polarized cells, where DRMs act as
organizational microdomains for membrane receptors,
signaling molecules and regulators of actin cytoskeleton.
It has been well proven that hypercholesterolemia is
associated with elevated levels of oxLDL [66–69]. OxLDL
can promote atherosclerosis development by inducing the
recruitment of platelet-activating factor receptor and
CD36 in detergent resistant membranes [70]. Another
study has demonstrated that oxLDL can induce the
depletion of cholesterol from endothelial caveolae (a
vesicular-type subset of detergent resistant membrane
microdomains) which promotes disruption of these chol-
esterol rich microdomains affecting associated processes
and thus endothelial dysfunction [71]. These observations
are consistent with the fact that hypercholesterolemia can
result in the depletion of plasma membrane cholesterol,
evidenced in a report on the currently discussed diet-
induced hypercholesterolemic apoE-deficient mice [72].
Different studies have demonstrated that oxLDL can
induce rapid polymerization of actin and in turn, the
formation of filamentous actin and actin stress fibers in
vascular endothelial cells [73] and monocytes [74] or mac-
rophages [75]. The authors concluded that oxLDL induces
the formation of actin stress fibers through the activation
of RhoA/Rho kinase pathway, observation confirmed by
another study performed on HUVECs [76].
Transforming protein RhoA and Ras-related C3 botu-
linum toxin substrate 1 (Rac1) are members of the Rho
family of small GTP-binding proteins. These proteins,
identified and quantified in our study as well, play key
roles in the organization of the cytoskeleton and also in
its coupling to the plasma membrane [77, 78]. It has
been demonstrated that the activation of Rac type
proteins induces membrane ruffling, while Rho, once
activated, determines the formation of stress fibers and
also regulates cell polarization and migration, trafficking
or proliferation and it is also implicated in the formation
of cell-extracellular matrix focal adhesions [79, 80].
Other studies have shown that these proteins, once
activated, are translocated from cytoplasm, via integrin
signaling [81, 82] to plasma membrane and concentrate
in DRM microdomains [83, 84]. Integrin signaling is im-
portant as well for the control of Rho activity and can be
modulated through mechanical changes in the cytoskel-
eton [85]. Also, it has been demonstrated that lipid rafts
are mediating growth cone guidance in the angiogenetic
process, through localized assembly of receptor-ligand
interactions, the afterwards cytoskeletal rearrangement
and local protein synthesis, including Src family kinases
and Rho GTPases [86].
We do acknowledge the fact that the present proteomic
findings may be attributed to the cellular heterogeneity in
correspondence with the DRMs’ isolation source.
However, the high level of ACE activity (specific marker
for the luminal surface of endothelium) measured in the
DRM enriched fractions (Fig. 1b) corroborated with the
extremely large surface of the pulmonary endothelium
provide us the basis to believe that the endothelial cells
were the major source of DRM extraction. Nevertheless,
recent publications [87] claimed the specific localization
of ACE2 on the lung epithelial cells. Indeed the procedure
used to isolate DRMs does not exclude the presence of
epithelial contribution to the protein profile of DRMs.
The specific enzymatic activity measurement based on
Hip-His-Leu substrate, and the mass spectrometric identi-
fication of the angiotensin I converting enzyme (P09470
Uniprot access code) positively support our statement.
Conclusions
Taken together, these data demonstrate clearly that DRM
microdomains are indeed essential biological structures
that preserve the integrated macromolecular components
involved in the key pathways that maintain the cellular
homeostasis and could be deregulated under stress fac-
tors, including hyperlipidemia. The differential proteomic
analysis proposed in this experimental strategy aimed to
identify the biological processes and key proteins located
at membrane level. The research strategy was based on
the concept that DRM microdomains are the main plat-
forms of protein-protein and protein-lipid interactions.
These connections fulfill numerous biological functions
governed by controlled energy production and specific
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signaling pathways that are maintained after the dras-
tic mechanical procedure used during the preparation.
The study, objectively and reliably, revealed a panel of
proteins of interest in hyperlipidemia that may easily
generate new downstream research applications. The
complex network of interactions and dependency
between the proteins involved in these dynamic path-
ways, evidenced by the mass spectrometry analysis,
may be used to design experiments in which to study
the different protein-protein interactions under hyper-
lipidemic stress.
Only recently, the most complete and up to date
lipid raft proteome database has been published [88].
It includes mammalian lipid raft associated proteins
reported by using various biochemical isolation
methods and high throughput analysis such as mass
spectrometry studies. Already including published
results of our group [7], this paper aims also to add
to the present collection a comprehensive list of
DRM proteins affected by the hyperlipidemic condi-
tion and statin treatment to further enhance the
current knowledge on these extraordinary structural
and functional molecular platforms.
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